These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1271696

  • 1. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K, Hartmann E, Schneider WH, Spona J, Matt K.
    Klin Wochenschr; 1976 May 01; 54(9):431-8. PubMed ID: 1271696
    [Abstract] [Full Text] [Related]

  • 2. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N.
    Contraception; 1984 Nov 01; 30(5):421-30. PubMed ID: 6440738
    [Abstract] [Full Text] [Related]

  • 3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 01; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 4. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P, Kapiotis S, Pärtan C, Schneider B, Wenzel R, Gaiger A, Speiser W.
    Ann Hematol; 1993 Jul 01; 67(1):33-6. PubMed ID: 8392873
    [Abstract] [Full Text] [Related]

  • 5. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H, Fagerhol MK.
    Scand J Haematol; 1974 Jul 01; 12(3):232-40. PubMed ID: 4831827
    [Abstract] [Full Text] [Related]

  • 6. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
    Greig HB.
    Acta Haematol; 1977 Apr 01; 58(3):138-44. PubMed ID: 409028
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb 15; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 10. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan 15; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J, Feichtinger W, Kindermann C, Schneider B, Mellinger U, Walter F, Moore C, Gräser T.
    Contraception; 1997 Aug 01; 56(2):67-75. PubMed ID: 9315414
    [Abstract] [Full Text] [Related]

  • 13. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J, Petersen KR, Skouby SO.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [Abstract] [Full Text] [Related]

  • 14. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun 01; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 15. Coagulation effects of oral contraception.
    Bonnar J.
    Am J Obstet Gynecol; 1987 Oct 01; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [Abstract] [Full Text] [Related]

  • 16. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA, Kazi AB, Kazi A, Ali N.
    J Pak Med Assoc (1951); 1972 Aug 01; 22(8):218-25. PubMed ID: 12305803
    [Abstract] [Full Text] [Related]

  • 17. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN, Koh S, Ratnam SS.
    Contraception; 1989 Apr 01; 39(4):369-83. PubMed ID: 2524360
    [Abstract] [Full Text] [Related]

  • 18. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME.
    Am J Obstet Gynecol; 1992 Oct 01; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [Abstract] [Full Text] [Related]

  • 19. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J, Seal US, Doe RP.
    J Clin Endocrinol Metab; 1973 Apr 01; 36(4):706-14. PubMed ID: 4119677
    [Abstract] [Full Text] [Related]

  • 20. Adrenocortical function of patients using oral contraceptives.
    Kauppila A, Järvinen PA, Ylöstalo P, Reinilä M.
    Acta Obstet Gynecol Scand; 1974 Apr 01; 53(2):155-9. PubMed ID: 4362662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.